Drug intelligence / Profile preview

EUK-134

Development stage
Unknown
Lead developer
Proteome Systems
Modality
Small Molecules
Administration
Topical
01

Overview

EUK-134 is a synthetic small molecule antioxidant that functions as a dual mimetic of the enzymes superoxide dismutase (SOD) and catalase. As a manganese-salen complex, it is designed to neutralize a broad spectrum of reactive oxygen species (ROS), including superoxide, hydrogen peroxide, and peroxynitrite, thereby protecting cells from oxidative stress. Originally developed by Eukarion, EUK-134 has been extensively investigated in preclinical research for potential therapeutic applications in neuroprotection (such as stroke and Alzheimer's disease), ischemia-reperfusion injury, and mitochondrial dysfunction. Although it has shown significant efficacy in various animal models, it has not progressed to human clinical trials for pharmaceutical use. However, it has gained commercial prominence as an active ingredient in high-end cosmetic formulations due to its potent anti-aging and skin-protective properties.

Other names
Chloro[[2,2'-[1,2-ethanediylbis[(nitrilo-κN)methylidyne]]bis[6-ethoxyphenolato-κO]](2-)]manganeseManganese, chloro[[2,2'-[1,2-ethanediylbis(nitrilomethylidyne)]bis[6-ethoxyphenolato]](2-)]-Ethylbisiminomethylguaiacol manganese chloride
02

Targets

Misfolded SOD1Neuraminidase

Beyond the preview

Go deeper on EUK-134.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EUK-134.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call